A detailed history of Advisors Asset Management, Inc. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 39,646 shares of HALO stock, worth $1.87 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
39,646
Previous 37,472 5.8%
Holding current value
$1.87 Million
Previous $1.96 Million 15.6%
% of portfolio
0.04%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$51.3 - $64.42 $111,526 - $140,049
2,174 Added 5.8%
39,646 $2.27 Million
Q2 2024

Aug 14, 2024

SELL
$37.81 - $52.4 $211,244 - $292,758
-5,587 Reduced 12.98%
37,472 $1.96 Million
Q1 2024

May 14, 2024

BUY
$33.68 - $41.95 $84,368 - $105,084
2,505 Added 6.18%
43,059 $1.75 Million
Q4 2023

Feb 14, 2024

SELL
$33.32 - $42.1 $158,503 - $200,269
-4,757 Reduced 10.5%
40,554 $1.5 Million
Q2 2023

Aug 14, 2023

SELL
$30.28 - $38.74 $8,629 - $11,040
-285 Reduced 0.63%
45,311 $1.63 Million
Q1 2023

May 12, 2023

BUY
$32.86 - $55.7 $56,913 - $96,472
1,732 Added 3.95%
45,596 $1.74 Million
Q4 2022

Feb 13, 2023

BUY
$40.06 - $59.44 $334,581 - $496,442
8,352 Added 23.52%
43,864 $2.5 Million
Q3 2022

Nov 08, 2022

BUY
$38.53 - $51.78 $28,589 - $38,420
742 Added 2.13%
35,512 $1.4 Million
Q2 2022

Aug 08, 2022

BUY
$37.35 - $48.3 $273,812 - $354,087
7,331 Added 26.72%
34,770 $1.53 Million
Q1 2022

May 17, 2022

SELL
$31.97 - $41.06 $17,231 - $22,131
-539 Reduced 1.93%
27,439 $1.09 Million
Q4 2021

Feb 15, 2022

BUY
$31.82 - $40.75 $47,284 - $60,554
1,486 Added 5.61%
27,978 $1.13 Million
Q3 2021

Nov 12, 2021

BUY
$38.47 - $46.42 $63,898 - $77,103
1,661 Added 6.69%
26,492 $1.08 Million
Q2 2021

Jul 30, 2021

BUY
$38.84 - $51.31 $134,813 - $178,097
3,471 Added 16.25%
24,831 $1.13 Million
Q1 2021

May 07, 2021

BUY
$39.51 - $51.45 $163,057 - $212,334
4,127 Added 23.95%
21,360 $890,000
Q4 2020

Feb 12, 2021

BUY
$25.81 - $43.62 $244,885 - $413,866
9,488 Added 122.5%
17,233 $736,000
Q3 2020

Nov 16, 2020

BUY
$25.74 - $29.63 $92,355 - $106,312
3,588 Added 86.31%
7,745 $204,000
Q2 2020

Aug 12, 2020

BUY
$16.25 - $26.81 $67,551 - $111,449
4,157 New
4,157 $111,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.57B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.